An experimental COVID-19 vaccine currently in Phase I trials being run by the University of Cape Town has a unique design that might allow it to offer better protection against current and future variants of the SARS-CoV-2 virus. Elri Voigt provides an update on the trial and unpacks the science behind this vaccine candidate.
It has been over a year since the world saw the first confirmed case of COVID-19, yet the science behind the virus’ physical impact on children remains relatively unclear. Kathryn Cleary spoke to two experts in paediatrics and immunology to get an update on what we have learnt so far.
While progress in the race for effective COVID-19 vaccines has been rapid and impressive, an effective HIV vaccine remains elusive. As part of Spotlight’s World AIDS Day 2020 coverage, Kathryn Cleary asks two of South Africa’s top vaccine researchers to update us on where we are in the race for an HIV vaccine.
The South African National Institute for Communicable Diseases on Tuesday declared multi-system inflammatory syndrome in children (MIS-C) a Notifiable Medical Condition. Elna Schütz spoke with doctors who have been treating this rare and dangerous condition.
Initial results from an antibody survey conducted in the Cape Town Metro indicate that of 2 700 pregnant women and people living with HIV making use of the public healthcare system, 40% have previously been infected with SARS-CoV-2. Adele Baleta has the details.
South Africa is consolidating its place in the race for a COVID-19 vaccine with its participation starting from next month in two new international trials of vaccine candidates. Adele Baleta reports.